1. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021
2. Surgical management and considerations for patients with localized high-risk prostate cancer;Fang;Curr Treat Options Oncol,2024
3. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol;Attard;Lancet,2022
4. Milonas D, Giesen A, Laenen A, et al. Effect of radical prostatectomy on survival for men with high-risk nonmetastatic prostate cancer features according to the STAMPEDE criteria: an EMPaCT study. Eur Urol Oncol. In press.
5. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial;Parker;Lancet,2018